Dosage for Kenalog 10 Injection is individualized based on the condition and patient response. Kenalog 10 Injection may interact with aminoglutethimide, birth control pills, hormone replacement therapy, blood thinners, cyclosporine, digoxin, insulin or diabetes medications you take by mouth, isoniazid, rifampin, seizure medication, antibiotics, aspirin, or other NSAIDs (nonsteroidal anti-inflammatory drugs). Tell your doctor all medications you are taking. Kenalog 10 Injection should be used during pregnancy only if prescribed. This medication may be harmful to a fetus. Infants born to mothers who have received corticosteroids during pregnancy should be observed for signs of hypoadrenalism. This medication can pass into breast milk and may harm a nursing baby. Consult your doctor before breastfeeding.
Sounds like they had a DeQuervain’s injection (if it’s intratendinous instead of just under the tendon sheath there can be a lot of resistance…especially if using a tuberculin syringe/needle), and then had either a trigger thumb injection or an intraarticular injection of the 1st carpometacarpal joint. Either way, they shouldn’t have had “nerve damage” from either injection. The “nerve damage” was probably already there. Without a pre- and post-injection EMG/NCS, it’s impossible to know for sure. The skin atrophy and other signs can be relatively common with kenalog and other insoluble steroids. I don’t what the “thumb locking” is unless the patient means trigger thumb. Some physicians will use sterile saline injections in the atrophied area to speed up the recovery.
Systemic corticosteroids can reactivate tuberculosis and should not be used in patients with a history of active tuberculosis, except when chemoprophylaxis is instituted concomitantly. The incidence or course of acute bacterial infection are probably minimally affected by inhaled triamcinolone. Application of topical corticosteroids to areas of infection, including tuberculosis of the skin, should be initiated or continued only if the appropriate antiinfective treatment is instituted. If the infection does not respond to the antimicrobial therapy, the concurrent use of the topical corticosteroid should be discontinued until the infection is controlled.